← Leaderboards
Rebecca S Buckley
Chosen Diagnostics, Inc.
$1,173,685
Attributed
$2,347,370
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2019–22$2M$1.5M$1M$500K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$2,347,370 · 2
By mechanism
R44$2,047,729 · 1
R41$299,641 · 1
Top collaborators
- Sunyoung Kim3 shared
Others in their field
Other Emerging Leaders on “Early Diagnosis”
- Ross D McDonald · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Bryan Faller · Decatur Memorial Hospital$26,356,185
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
Research focus
Early DiagnosisFecesDiagnosisDysbiosisEconomicsEnrollmentAccurate DiagnosisCountryDiagnosticDisease DiagnosisContractsBiological MarkersAlkaline PhosphataseBirthBirth WeightAmericanCaringAntibiotic TherapyCharacteristicsAffectClinical DataDisabilityCommercializationFeeds
Grant awards (3)
Noninvasive biomarkers for gastrointestinal disease in preterm infants$1,056,686
R44 · FY2022 · HD · contact PI
Noninvasive biomarkers for gastrointestinal disease in preterm infants$991,043
R44 · FY2021 · HD · contact PI
Noninvasive biomarkers for gastrointestinal disease in preterm infants$299,641
R41 · FY2019 · HD · contact PI